Anagenics Limited (AU:AN1) has released an update.
Anagenics Limited reported its Q1 FY25 financial performance, highlighting cash receipts of $2.1 million and a net operating cash outflow of $928,000. The company is focusing on restructuring its business model to achieve profitability and expects significant cost savings from Q2 FY25, aiming for a positive cash flow from November 2024. Anagenics continues to expand its health and beauty-tech business, enhancing shareholder value through global distribution of its anti-aging solutions.
For further insights into AU:AN1 stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
